Chris Ahlers

Chris Ahlers, MD, currently serves as Senior Medical Director at I-Mab Biopharma since July 2024, following a similar role at Arcus Biosciences from December 2022 to March 2024. Prior experience includes Senior Director of Clinical Development at Replimune (August 2021 - October 2022) and Project Physician Lead at GSK (November 2014 - July 2021), where responsibilities encompassed designing translational research plans and executing clinical studies. Additionally, Chris held the position of Medical Director in Oncology Early Clinical & Translational Research at Bristol-Myers Squibb (July 2007 - October 2014) and gained foundational experience as Clinical Fellow at the National Cancer Institute (2004 - 2007) and Medical Resident at Hahnemann University Hospital (2001 - 2004). Educational credentials include a Fellowship in Medical Oncology from the National Cancer Institute and an MD from Medizinische Hochschule Hannover, complemented by a BA in Biology from Middlebury College.